Assessment of COVID-19-related meta-analysis reporting quality
© 2021. Royal Academy of Medicine in Ireland..
BACKGROUND: Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic.
METHODS: The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different characteristics, and we determined the quality of reporting using the AMSTAR tool, an 11-items tool that assesses the content validity and methodological quality of systematic reviews and meta-analysis.
RESULTS: A total of 538 studies were included in our assessment. The first meta-analysis included was published in March, while the last one was on the 31st of October. Upon comparing the mean AMSTAR score for meta-analysis published during each month, we found a significant difference (p < 0.001, F = 4.139), where the mean score almost steadily increased since March.
CONCLUSION: The urge to publish during the COVID-19 period or any other surge in publishing should not be at the expense of quality.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:191 |
|---|---|
| Enthalten in: |
Irish journal of medical science - 191(2022), 3 vom: 06. Juni, Seite 1047-1051 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Al-Ryalat, Nosaiba [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AMSTAR |
|---|
| Anmerkungen: |
Date Completed 30.05.2022 Date Revised 30.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11845-021-02710-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327735260 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327735260 | ||
| 003 | DE-627 | ||
| 005 | 20231225201436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11845-021-02710-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327735260 | ||
| 035 | |a (NLM)34227034 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Al-Ryalat, Nosaiba |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessment of COVID-19-related meta-analysis reporting quality |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.05.2022 | ||
| 500 | |a Date Revised 30.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Royal Academy of Medicine in Ireland. | ||
| 520 | |a BACKGROUND: Meta-analysis of high-quality primary articles represents the top-quality evidence in medical literature. In this project, our aim was to assess the number and quality of COVID-related meta-analysis published since the beginning of the COVID-19 pandemic | ||
| 520 | |a METHODS: The search included the period from January 1, 2020, when the beginning of primary articles on COVID-19, till October 31, 2020. We screened a total of 793 studies. We excluded non-meta-analytic non-COVID-19-related studies. We obtained different characteristics, and we determined the quality of reporting using the AMSTAR tool, an 11-items tool that assesses the content validity and methodological quality of systematic reviews and meta-analysis | ||
| 520 | |a RESULTS: A total of 538 studies were included in our assessment. The first meta-analysis included was published in March, while the last one was on the 31st of October. Upon comparing the mean AMSTAR score for meta-analysis published during each month, we found a significant difference (p < 0.001, F = 4.139), where the mean score almost steadily increased since March | ||
| 520 | |a CONCLUSION: The urge to publish during the COVID-19 period or any other surge in publishing should not be at the expense of quality | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a AMSTAR | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Meta-analysis | |
| 650 | 4 | |a Quality | |
| 700 | 1 | |a Al-Rashdan, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Alaaraj, Bayan |e verfasserin |4 aut | |
| 700 | 1 | |a Toubasi, Ahmad A |e verfasserin |4 aut | |
| 700 | 1 | |a Alsghaireen, Hadil |e verfasserin |4 aut | |
| 700 | 1 | |a Yaseen, Abeer |e verfasserin |4 aut | |
| 700 | 1 | |a Mesmar, Ahmad |e verfasserin |4 aut | |
| 700 | 1 | |a AlRyalat, Saif Aldeen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Irish journal of medical science |d 1945 |g 191(2022), 3 vom: 06. Juni, Seite 1047-1051 |w (DE-627)NLM000148970 |x 1863-4362 |7 nnns |
| 773 | 1 | 8 | |g volume:191 |g year:2022 |g number:3 |g day:06 |g month:06 |g pages:1047-1051 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11845-021-02710-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 191 |j 2022 |e 3 |b 06 |c 06 |h 1047-1051 | ||